Floatz logo

BENZTROPINE

Back Pain

VA Office of Research and DevelopmentSmall moleculePhase 2Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Back Pain cohort.

Asset / SponsorPhaseRating
Oxycodone
Grünenthal GmbH
Phase 4BBB
Bxcl501
Medical College of Wisconsin
Phase 4BB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB
PROPOFOL
Medical College of Wisconsin
Phase 4BB
NEPENTHE
MedtronicNeuro
Phase 4BB

View all 41 →

Same molecule, other indications

BENZTROPINE is also rated in:

schizoaffective disorderDormant
B
Indicative ·
63 / 100
View asset →
schizophreniaDormant
B
Indicative ·
57 / 100
View asset →
sciaticaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →